- Investing Ideas
- /
- Pakistani Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Pakistani Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
5
High return on equity, past performance and sound balance sheet.
5 companies
GlaxoSmithKline Pakistan
Market Cap: PK₨133.1b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨417.92
7D
-2.8%
1Y
90.6%
Abbott Laboratories (Pakistan)
Market Cap: PK₨119.7b
Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.
ABOT
PK₨1,222.71
7D
2.2%
1Y
49.5%
Highnoon Laboratories
Market Cap: PK₨61.0b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨1,150.40
7D
1.1%
1Y
47.8%
Hoechst Pakistan
Market Cap: PK₨41.5b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨4,307.73
7D
3.8%
1Y
83.3%
Macter International
Market Cap: PK₨16.4b
A contract manufacturer, manufactures and markets pharmaceutical products and formulations for healthcare companies in Pakistan.
MACTER
PK₨358.05
7D
-3.2%
1Y
189.3%